Koshiba M, Ogawa O, Habuchi T, Hamazaki S, Shimada T, Takahashi R, Sugiyama T
Department of Geriatric Medicine, Kyoto University.
Jpn J Cancer Res. 1993 Feb;84(2):163-7. doi: 10.1111/j.1349-7006.1993.tb02850.x.
Mutations of ras oncogenes in 37 human stomach cancers and 13 adenomas were investigated with regard to the histological phenotypes using polymerase chain reaction (PCR), allele-specific oligonucleotide hybridization and/or direct sequencing of the PCR products. The ras mutation was found only in one case (2.7%), the histology of which was poorly differentiated adenocarcinoma. We found no mutation in stomach adenomas. The mutation consisted of a guanine-to-adenine transition in the first base of codon 13 of c-Ki-ras which replaced wild-type glycine with serine, indicating that a putative glycine-to-aspartic acid change is not necessarily the critical event for c-Ki-ras gene activation in codon 13. These results further confirm the infrequency of ras mutation in stomach tumors and also suggest that ras mutations are not specific to the differentiated type of stomach cancer.
运用聚合酶链反应(PCR)、等位基因特异性寡核苷酸杂交和/或PCR产物直接测序技术,针对37例人类胃癌和13例胃腺瘤的组织学表型,对ras癌基因的突变情况展开研究。仅在1例(2.7%)组织学类型为低分化腺癌的病例中发现了ras突变。在胃腺瘤中未发现突变。该突变是c-Ki-ras第13密码子第一个碱基由鸟嘌呤向腺嘌呤的转变,此转变使得野生型甘氨酸被丝氨酸取代,这表明第13密码子中假定的甘氨酸向天冬氨酸的改变未必是c-Ki-ras基因激活的关键事件。这些结果进一步证实了ras突变在胃肿瘤中罕见,同时也提示ras突变并非胃腺癌特定分化类型所特有。